Arvinas (ARVN) Interest Expenses (2017 - 2021)
Arvinas (ARVN) recorded quarterly Interest Expenses of $67500.0 in Q4 2021, up 730.77% quarter-over-quarter from $8125.0 in Q3 2021, and up 31.71% on a YoY basis from $51250.0 in Q4 2020.
Arvinas (ARVN) Interest Expenses (2017 - 2021) Analysis & Trends
Arvinas' Interest Expenses history runs 5 years deep, the most recent figure standing at $67500.0 for Q4 2021.
- In Q4 2021, Interest Expenses rose 31.71% year-over-year to $67500.0; the TTM figure through Sep 2022 stood at $67500.0 (down 19.4% YoY), while the FY2021 annual figure was $100000.0, changed 0.0% from the prior year.
- Interest Expenses was $67500.0 for Q4 2021 at Arvinas, up from $8125.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $67500.0 in Q4 2021 to a low of $8125.0 in Q2 2021.
- Historically, Interest Expenses has averaged $19668.2 across 5 years, with a median of $16250.0 in 2019.
- The sharpest annual moves came in 2020 and 2021: Interest Expenses surged 215.38% in 2020, then sank 50.0% in 2021.
- A 5-year view of Interest Expenses shows it stood at $11451.0 in 2017, then surged by 115.14% to $24636.0 in 2018, then slumped by 34.04% to $16250.0 in 2019, then soared by 215.38% to $51250.0 in 2020, then jumped by 31.71% to $67500.0 in 2021.
- The last three Interest Expenses figures came in at $67500.0 (Q4 2021), $8125.0 (Q3 2021), and $8125.0 (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 67,500.00 |
| Dec 31, 2021 | 67,500.00 |
| Sep 30, 2021 | 8,125.00 |
| Sep 30, 2021 | 8,125.00 |
| Jun 30, 2021 | 8,125.00 |
| Jun 30, 2021 | 8,125.00 |
| Mar 31, 2021 | 16,250.00 |
| Mar 31, 2021 | 16,250.00 |
| Dec 31, 2020 | 51,250.00 |
| Dec 31, 2020 | 51,250.00 |
| Sep 30, 2020 | 16,250.00 |
| Sep 30, 2020 | 16,250.00 |
| Jun 30, 2020 | 16,250.00 |
| Jun 30, 2020 | 16,250.00 |
| Mar 31, 2020 | 16,250.00 |
| Mar 31, 2020 | 16,250.00 |
| Dec 31, 2019 | 16,250.00 |
| Dec 31, 2019 | 16,250.00 |
| Sep 30, 2019 | 22,903.00 |
| Sep 30, 2019 | 22,903.00 |